CBD is one of the fasting growing industries in the world right now, though it has been around for years. CBD is found in the cannabis plant but doesn’t have the psychoactive effects that THC does. The substance provides a therapeutic effect on the body, reducing stress and physical pain. The new Farm Bill of 2018 makes it possible to cultivate hemp legally.
What Is Spero for DNA?
Spero for DNA is a brain that offers high quality products, though the business model is based on crowdfunding. The company aims to bring in investors that can help with their “sustainable, community approach” to get CBD to the people that need it the most.
Production of Spero Products
The formulas from Spero are created with Liquid Chromatography, rather than Distillation, which is used by other brands. The website offers this graphic to demonstrate the process.
Why Invest in Spero?
The main reason to invest in this company is to be a part of a growing industry that seems to be on a steady upward path. Plant-based medications are thriving right now, and the products available through Spero use the whole plant in the production, with organic processes during growth. Spero intends to secure customers through online sales, and there will be a monthly subscription plan after the company officially launches.
Along with the profits that investors stand to make, Spero plans to dedicate 3% of the sales to a fund for individuals that are in need of CBD. They have already partnered with the Brazilian Association of Epilepsy, and plan to create products that are specifically balanced for Alzheimer’s patients, opioid addicts, and even pets.
Investments in this project can be made by clicking the link on the official website. At the time of writing, Spero CBD had raised $45,275, though there are still 68 days of funding left. The full details on this investment can be viewed at startengine.com/spero-cbd.
For More Information
For potential investors that have other questions, Spero can be reached by sending an email to email@example.com or submitting a question on the investment page.